BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 26657161)

  • 1. Targeting Iron Deficiency Anemia in Heart Failure.
    Saraon T; Katz SD
    Prog Cardiovasc Dis; 2016; 58(4):407-15. PubMed ID: 26657161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia.
    Beck-da-Silva L; Piardi D; Soder S; Rohde LE; Pereira-Barretto AC; de Albuquerque D; Bocchi E; Vilas-Boas F; Moura LZ; Montera MW; Rassi S; Clausell N
    Int J Cardiol; 2013 Oct; 168(4):3439-42. PubMed ID: 23680589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of intravenous and oral iron in chronic kidney disease.
    Agarwal R; Kusek JW; Pappas MK
    Kidney Int; 2015 Oct; 88(4):905-14. PubMed ID: 26083656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: a randomized trial.
    Froessler B; Cocchiaro C; Saadat-Gilani K; Hodyl N; Dekker G
    J Matern Fetal Neonatal Med; 2013 May; 26(7):654-9. PubMed ID: 23130909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal Serum Ferritin Levels for Iron Deficiency Anemia during Oral Iron Therapy (OIT) in Japanese Hemodialysis Patients with Minor Inflammation and Benefit of Intravenous Iron Therapy for OIT-Nonresponders.
    Takasawa K; Takaeda C; Wada T; Ueda N
    Nutrients; 2018 Mar; 10(4):. PubMed ID: 29596361
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral or intravenous iron for anemia correction in chronic kidney disease?
    Drüeke TB; Massy ZA
    Kidney Int; 2015 Oct; 88(4):673-5. PubMed ID: 26422625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous iron sucrose v/s oral ferrous fumarate for treatment of anemia in pregnancy. A randomized controlled trial.
    Bhavi SB; Jaju PB
    BMC Pregnancy Childbirth; 2017 May; 17(1):137. PubMed ID: 28482869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic kidney disease: Serious adverse effects associated with IV iron in CKD.
    Allison SJ
    Nat Rev Nephrol; 2015 Sep; 11(9):506. PubMed ID: 26149838
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of 6-months of oral ferrous and ferric supplement therapy in patients who were hospitalized for decompensated chronic heart failure.
    Zdravkovic SC; Nagorni SP; Cojbasic I; Mitic V; Cvetkovic P; Nagorni I; Govedarovic N; Davinic I; Stanojevic D
    J Int Med Res; 2019 Jul; 47(7):3179-3189. PubMed ID: 31189356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous iron therapy in patients with heart failure. A double-edged sword.
    Lippi G; Sanchis-Gomar F; Cervellin G
    Int J Cardiol; 2013 Oct; 168(5):4863. PubMed ID: 23890881
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of Total Dose Infusion of Iron Intravenously in Patients With Acute Heart Failure and Anemia (Hemoglobin < 13 g/dl).
    Kaminsky BM; Pogue KT; Hanigan S; Koelling TM; Dorsch MP
    Am J Cardiol; 2016 Jun; 117(12):1942-6. PubMed ID: 27161817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron therapy in patients with heart failure. A straight shot.
    Beck-da-Silva L; Rohde LE; Clausell N
    Int J Cardiol; 2013 Oct; 168(5):5071-2. PubMed ID: 23931974
    [No Abstract]   [Full Text] [Related]  

  • 13. Iron deficiency in chronic and acute heart failure: A contemporary review on intertwined conditions.
    Cunha GJL; Rocha BML; Menezes Falcão L
    Eur J Intern Med; 2018 Jun; 52():1-7. PubMed ID: 29680173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous iron products.
    Johnson CA; Mason NA; Bailie GR
    ANNA J; 1999 Oct; 26(5):522-4. PubMed ID: 10776081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron.
    Toblli JE; Di Gennaro F; Rivas C
    Heart Lung Circ; 2015 Jul; 24(7):686-95. PubMed ID: 25666998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous iron sucrose: an alternative for oral iron in pregnancy with iron deficiency anemia.
    Shi Q; Li J; Yao Q; Mi C; Yang J; Xing A
    Ann Hematol; 2015 Mar; 94(3):523-5. PubMed ID: 25123238
    [No Abstract]   [Full Text] [Related]  

  • 17. Anemia and heart failure a new pathway?
    Francis GS; Kanderian A
    J Am Coll Cardiol; 2007 Oct; 50(17):1666-7. PubMed ID: 17950148
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the Efficacies of Parenteral Iron Sucrose and Oral Iron Sulfate for Anemic Patients with Inflammatory Bowel Disease in Korea.
    Han YM; Yoon H; Shin CM; Koh SJ; Im JP; Kim BG; Kim JS; Jung HC
    Gut Liver; 2016 Jul; 10(4):562-8. PubMed ID: 27021505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous ferrous sucrose versus placebo in addition to oral iron therapy for the treatment of severe postpartum anaemia: a randomised controlled trial.
    Perelló MF; Coloma JL; Masoller N; Esteve J; Palacio M
    BJOG; 2014 May; 121(6):706-13. PubMed ID: 24423186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of available intravenous iron preparations in hemodialysis.
    Palmer K; Cameron K; Battistella M
    CANNT J; 2013; 23(2):51-4; quiz 55-6. PubMed ID: 24069699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.